Medicare Enrolled
Dr. Lucio Gordan, MD
Hematology · Gainesville, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gordan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gordan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gordan
Dr. Lucio Gordan is a hematology specialist in Gainesville, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gordan performed 89,308 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gordan received a total of $42,442 from 65 pharmaceutical and/or device companies across 192 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gordan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 48% volume in FL
$42,442 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗89,308
Medicare services
Top 48% in FL for hematology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
36,210 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 9,750 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 9,180 | $19 | $51 |
| Paclitaxel chemotherapy injection | 8,761 | $0 | $2 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
6,200 | $6 | $23 |
| Iron infusion (Monoferric) | 4,700 | $16 | $57 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,840 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,276 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,106 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,230 | $1 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,180 | $93 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 564 | $0 | $9 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
503 | $10 | $69 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
373 | $96 | $378 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
348 | $12 | $61 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
343 | $21 | $84 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
315 | $47 | $189 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
278 | $6 | $69 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
194 | $1 | $3 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
184 | $15 | $59 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
165 | $21 | $79 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
147 | $55 | $206 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
135 | $1 | $6 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
131 | $10 | $42 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
130 | $58 | $239 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
126 | $4 | $10 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
121 | $47 | $178 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
104 | $25 | $89 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
103 | $130 | $474 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 91 | $114 | $562 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
66 | $121 | $453 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
65 | $2 | $8 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
61 | $15 | $56 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
60 | $2 | $7 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
49 | $1 | $7 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
44 | $27 | $156 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
40 | $23 | $156 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
36 | $40 | $170 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
33 | $66 | $277 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
32 | $4 | $15 |
| New patient office visit, complex (60-74 min) | 21 | $151 | $585 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
13 | $158 | $533 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
47.3% high complexity
45.4% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$42,442
Total received (2018-2024)
Avg $6,063/year across 7 years
Top 11% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
192
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,937
2023
$7,767
2022
$9,222
2021
$1,925
2020
$4,181
2019
$8,090
2018
$5,321
Payments by company (2024)
Janssen Biotech, Inc.
$4,424
PFIZER INC.
$459
Genentech USA, Inc.
$261
McKesson Drug Company LLC
$233
Astellas Pharma US Inc
$168
Spectrum Pharmaceuticals Inc.
$107
Celgene Corporation
$97
Novartis Pharmaceuticals Corporation
$60
Karyopharm Therapeutics Inc.
$41
JAZZ PHARMACEUTICALS INC.
$26
Gilead Sciences, Inc.
$25
Octapharma USA, Inc.
$21
GENZYME CORPORATION
$14
Top 3 companies account for 86.7% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$9,530
Illumina, Inc.
$5,876
Celgene Corporation
$4,549
E.R. Squibb & Sons, L.L.C.
$3,882
Jazz Pharmaceuticals Inc.
$2,250
SANOFI-AVENTIS U.S. LLC
$1,871
AbbVie, Inc.
$1,650
GENZYME CORPORATION
$1,619
Novartis Pharmaceuticals Corporation
$1,476
Seattle Genetics, Inc.
$1,402
MorphoSys, US Inc.
$1,338
AVEO Pharmaceuticals, Inc.
$900
PFIZER INC.
$728
Janssen Global Services, LLC
$585
Ipsen Biopharmaceuticals, Inc
$519
Amgen Inc.
$430
Genentech USA, Inc.
$329
Daiichi Sankyo Inc.
$328
Astellas Pharma US Inc
$268
McKesson Drug Company LLC
$233
Foundation Medicine, Inc.
$225
Spectrum Pharmaceuticals Inc.
$189
BeiGene USA, Inc.
$176
Bayer Healthcare Pharmaceuticals Inc.
$169
ASD Specialty Healthcare, LLC
$146
Lilly USA, LLC
$141
Clovis Oncology, Inc.
$130
ASD SPECIALTY HEALTHCARE, LLC
$126
Pharmacyclics LLC, An AbbVie Company
$112
Bayer HealthCare Pharmaceuticals Inc.
$108
AmerisourceBergen Drug Corporation
$93
AMAG Pharmaceuticals, Inc.
$90
Adaptive Biotechnologies Corporation
$82
Boehringer Ingelheim Pharmaceuticals, Inc.
$82
Merck Sharp & Dohme Corporation
$79
Mirati Therapeutics, Inc.
$72
Karyopharm Therapeutics Inc.
$55
TESARO, Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$43
NanoString Technologies, Inc.
$36
MEDIVATION FIELD SOLUTIONS LLC
$31
CTI BioPharma Corp.
$28
TerSera Therapeutics LLC
$27
JAZZ PHARMACEUTICALS INC.
$26
Gilead Sciences, Inc.
$25
EMD Serono, Inc.
$25
EISAI INC.
$24
Exelixis Inc.
$23
Octapharma USA, Inc.
$21
AbbVie Inc.
$21
Myriad Genetic Laboratories, Inc.
$18
Aurobindo Pharma USA, Inc.
$18
Taiho Oncology, Inc.
$18
Seagen Inc.
$17
GlaxoSmithKline, LLC.
$16
Agios Pharmaceuticals, Inc.
$16
PharmaEssentia USA Corporation
$16
Eisai Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
Merck Sharp & Dohme LLC
$15
Sun Pharmaceutical Industries Inc.
$14
GE HealthCare
$14
Kite Pharma, Inc.
$13
SERVIER PHARMACEUTICALS LLC
$13
Veracyte, Inc.
$6
Top 3 companies account for 47.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Abraxane · Alecensa · BESREMI · BOSULIF · BRUKINSA · Bavencio · Cabometyx · DARZALEX · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · Erleada · FEMARA · FERAHEME · FOTIVDA · FOUNDATIONONE · GAMMAGARD · GAZYVA · GILOTRIF · Herceptin · IDHIFA · IMBRUVICA · INLYTA · Imbruvica · JEVTANA · Jivi · KEYTRUDA · KISQALI · KRAZATI · KYMRIAH · Kyprolis · LONSURF · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · Neulasta · NovaSeq 6000Dx Sequencer Instrument · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPDIVO · Oncology Testing · Onivyde · PROMACTA · PROSIGNA ASSAY · Padcev · Pomalyst · Prolia · REBLOZYL · ROLVEDON · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · TECVAYLI · TIBSOVO · TUKYSA · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XPOVIO · XTANDI · Xofigo · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
8
County median income
$59,659
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA NORTH FLORIDA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gordan is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gordan experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Gordan performed 36,210 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gordan receive payments from pharmaceutical companies?
Yes. Dr. Gordan received a total of $42,442 from 65 companies across 192 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gordan's costs compare to other hematologists in Gainesville?
Dr. Gordan's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gordan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Gainesville
Browse hematologists in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Illumina, Inc. Payments to Doctors
See all physicians who received payments from Illumina, Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology